Congleton Jon

Average Profitability
24.98%
Insider Buys Quantity
4
Insider Buys Sum
$105,540.93
Insider Sells Quantity
8
Insider Sells Sum
$1.93M

Insider Activity of Congleton Jon

According to the SEC Form 4 filings, Congleton Jon, being in a position of

  1. Chief Executive Officer at Mineralys Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 153127 shares for $1.93M,
    over all time since 2023-08-11, has bought 10750 shares for $105,541, and sold 153127 shares for $1.93M.

The largest purchase of all time was on 2023-08-17 and amounted to 2250 shares of Mineralys Therapeutics, Inc. for $27,225.

The largest sale of all time was on 2024-06-13 and amounted to 39961 share of Mineralys Therapeutics, Inc. for $509,027.

Biography of Congleton Jon

No biography is available at this moment.

2024-10-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,271
0.0325%
$13.52$206,433-2.14%
2024-07-11SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
15,746
0.0331%
$13.34$210,075-7.88%
2024-06-20SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
14,940
0.0276%
$11.73$175,237+6.32%
2024-06-18SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,607
0.0313%
$11.99$199,073+5.51%
2024-06-17SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
17,766
0.0343%
$12.25$217,712+1.89%
2024-06-14SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,229
0.032%
$12.52$203,163-1.27%
2024-06-13SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
39,961
0.0801%
$12.74$509,027-2.05%
2024-06-12SaleMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
16,607
0.0334%
$12.77$212,013-1.27%
2023-11-22PurchaseMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
4,250
0.004%
$5.97$25,356+109.06%
2023-09-06PurchaseMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
2,250
0.0043%
$12.08$27,180-2.15%
2023-08-17PurchaseMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
2,250
0.0043%
$12.10$27,225-1.31%
2023-08-11PurchaseMineralys Therapeutics, Inc.
MLYS
Chief Executive Officer
2,000
0.0041%
$12.89$25,780-5.7%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.